SCHEMBL12966549

SCHEMBL12966549

CN(C)N=Nc1ccc(S(=O)(=O)c2ccc(OCCC(=O)O)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.48
▸ L3MBTL1 Q9Y468 2/20 0.48
▸ LMNA P02545 2/20 0.47
▸ LTA4H P09960 6/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ NPC1 O15118 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ MMP2 P08253 3/20 0.40
▸ GAA P10253 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ MMP1 P03956 1/20 0.39
▸ MMP3 P08254 1/20 0.39
▸ MMP9 P14780 1/20 0.39
▸ MMP12 P39900 1/20 0.39
▸ MMP13 P45452 1/20 0.39
▸ MMP14 P50281 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12966547 0.93 ALDH1A1 (0.46) ALDH1A1L3MBTL1LMNALTA4HKDM4E
SCHEMBL12966654 0.86 GAA (0.54) ALDH1A1L3MBTL1LMNALTA4HKDM4E
SCHEMBL12966540 0.85 LTA4H (0.60) L3MBTL1LMNALTA4HNPC1MAPT
SCHEMBL38663 0.85 PPARA (0.51) L3MBTL1LMNALTA4HNPC1MAPT
SCHEMBL43048 0.85 PPARA (0.51) L3MBTL1LMNALTA4HNPC1MAPT
SCHEMBL12966531 0.84 L3MBTL1 (0.47) L3MBTL1LMNALTA4HKDM4ENPC1
SCHEMBL12966899 0.82 GAA (0.52) ALDH1A1L3MBTL1LMNALTA4HKDM4E
SCHEMBL12966546 0.79 PPARA (0.57) L3MBTL1LMNALTA4HNPC1MAPT
SCHEMBL12966674 0.78 PPARA (0.63) L3MBTL1LTA4HNPC1MAPTRAB9A
SCHEMBL2475367 0.78 LMNA (0.72) ALDH1A1LMNAKDM4ENPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012130850-A1 TISSUE TARGETING BY MEANS OF ONCOCIDAL BRIDGED DIPHENYL DERIVATIVES FOR THE SELECTIVE TREATMENT OF SEXUAL ORGAN TUMORS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-10-04 — — WO disclosed
Send feedback